A REVIEW OF SEMAGLUTIDE

Semaglutide has long been revealed to induce medullary thyroid cell carcinoma in rodents. While its scientific relevance to human beings is unfamiliar, the FDA advises never to administer this drug in those with a private or loved ones history of medullary thyroid carcinoma. Semaglutide also poses a chance of pancreatitis and dehydration.Triple hor